INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 100 filers reported holding INARI MED INC in Q3 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,510,602 | +561.1% | 114,841 | +487.8% | 0.01% | +500.0% |
| Q2 2023 | $1,135,998 | +208.4% | 19,539 | +227.5% | 0.00% | – |
| Q1 2023 | $368,403 | -21.1% | 5,967 | -18.8% | 0.00% | – |
| Q4 2022 | $467,102 | -49.9% | 7,349 | -42.8% | 0.00% | -100.0% |
| Q3 2022 | $933,000 | -49.6% | 12,853 | -52.8% | 0.00% | 0.0% |
| Q2 2022 | $1,851,000 | +257.3% | 27,208 | +375.7% | 0.00% | – |
| Q1 2022 | $518,000 | -56.3% | 5,719 | -56.0% | 0.00% | -100.0% |
| Q4 2021 | $1,186,000 | +78.3% | 12,996 | +58.5% | 0.00% | – |
| Q3 2021 | $665,000 | -14.4% | 8,201 | -1.4% | 0.00% | – |
| Q2 2021 | $777,000 | -2.6% | 8,320 | +11.7% | 0.00% | -100.0% |
| Q1 2021 | $798,000 | +23.0% | 7,450 | +0.2% | 0.00% | – |
| Q4 2020 | $649,000 | +344.5% | 7,435 | +251.4% | 0.00% | – |
| Q3 2020 | $146,000 | – | 2,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |